Role of steroids in fungal rhinosinusitis
Reading File
Finding Sources
Finding Sources
Searching PubMed
steroids fungal rhinosinusitis treatment
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Reading File
I now have comprehensive information from multiple authoritative textbooks. Let me compile the final answer.
Role of Steroids in Fungal Rhinosinusitis
Fungal rhinosinusitis (FRS) is broadly classified into non-invasive (fungal ball, allergic fungal rhinosinusitis) and invasive (acute, chronic granulomatous, chronic non-granulomatous) forms. The role of steroids differs fundamentally between these categories.
1. Allergic Fungal Rhinosinusitis (AFRS) - The Primary Indication
AFRS is a Type I (and possibly Type III) hypersensitivity reaction to inhaled fungal antigens in atopic, immunocompetent individuals. The eosinophilic inflammatory cascade makes it the one form of FRS where steroids have a well-established and central role.
Rationale for Use
The underlying mechanism is an IgE-mediated hypersensitivity reaction (analogous to ABPA) producing eosinophilic mucin, nasal polyposis, and local inflammation. Steroids suppress this eosinophilic/allergic cascade. Patients typically show an excellent response to oral corticosteroids but not antibiotics - a clinical clue that helps differentiate AFRS from bacterial CRS. - Scott-Brown's Otorhinolaryngology Vol 1, p.261
A. Oral (Systemic) Corticosteroids
Perioperative use: Systemic steroids are started perioperatively (usually beginning around the time of surgery), then tapered over several days to weeks. They help reduce mucosal oedema, shrink polyps, and improve surgical access. They may also aid disease remission post-surgery. - Cummings Otolaryngology, p.892
Post-operative use: Gan et al. (2014) published an evidence-based review that recommends post-operative systemic steroids (Grade B evidence from four studies, including two level 2b and two level 4 studies; n=76 AFRS patients). These studies reported a significant reduction in post-operative mucosal disease and inflammatory markers. - Scott-Brown's Otorhinolaryngology Vol 1, p.262
A prospective, randomized, placebo-controlled trial by Rupa et al. (2010) compared oral prednisolone vs. placebo post-operatively (n=12 each arm) and concluded that post-operative oral steroid in a tapering dose produces significant subjective and objective improvement in AFRS patients. - Scott-Brown's Otorhinolaryngology Vol 1, p.262
Limitations: High-dose corticosteroids carry significant side effects (hyperglycemia, bone loss, adrenal suppression), and disease recurrence may occur after cessation of systemic steroids. - Cummings Otolaryngology, p.892
B. Topical (Intranasal) Corticosteroids
Topical nasal steroids achieve effective drug concentration at the sinonasal mucosa with few systemic side effects and are recommended by Gan et al. (Grade B). They are used in nasal saline irrigations post-operatively and provide long-term maintenance without the side-effect burden of systemic steroids.
However, the evidence is not uniformly strong: one RCT comparing post-operative topical nasal steroids + nasal douching vs. nasal douching alone vs. nasal douching + itraconazole showed no significant benefit at 6 months for topical nasal steroids, though the study had significant limitations. - Scott-Brown's Otorhinolaryngology Vol 1, p.262
Despite this, post-operative topical corticosteroid therapy mixed with saline irrigations is widely advocated to reduce dependence on systemic steroids and prevent relapse. - Cummings Otolaryngology, p.892
Summary of Steroid Regimen in AFRS
| Phase | Route | Purpose |
|---|---|---|
| Perioperative | Oral (tapering) | Reduce polyp/mucosal burden, improve surgical field |
| Post-operative (short-term) | Oral (tapering) | Reduce recurrence, control residual mucosal disease |
| Post-operative (long-term) | Topical intranasal (+ saline irrigation) | Maintenance, minimize systemic steroid exposure |
2. Fungal Ball (Mycetoma) - No Role for Steroids
The treatment is purely surgical: complete removal of fungal debris by ESS with large antrostomy/ostioplasty and thorough irrigation. No further medical therapy (including steroids) is required in most cases after successful debridement. - Cummings Otolaryngology, p.875
3. Invasive Fungal Rhinosinusitis (IFRS) - Steroids are Contraindicated
IFRS occurs almost exclusively in severely immunocompromised patients (uncontrolled diabetes, haematological malignancies, solid organ transplant recipients, prolonged neutropenia). The treatment triad is:
- Reversal of the underlying immunodeficiency (the single most important factor for survival)
- Systemic antifungal therapy (broad-spectrum initially, then culture-directed)
- Aggressive surgical debridement of all avascular and necrotic tissue until healthy bleeding tissue is reached
Steroids have no role here and are potentially harmful. They would further suppress the already-compromised immune system, worsen neutrophil function, and promote uncontrolled fungal spread. If the immunocompromised status is profound and irreversible, even surgical treatment is unlikely to be successful. The prognosis in IFRS remains grim despite optimal treatment. - Cummings Otolaryngology, p.875-876
4. Interaction with Antifungals in AFRS
In AFRS patients refractory to surgery and oral/topical steroids, itraconazole (200-400 mg daily in divided doses for up to 6 months) can be combined with steroids to:
- Reduce the fungal antigen load driving the hypersensitivity
- Reduce dependence on oral steroids
- Prevent disease recurrence and the need for revision surgery
One cohort of 139 AFRS patients treated with high-dose post-operative itraconazole combined with oral and topical steroids showed a significant reduction in the need for revision surgery. - Scott-Brown's Otorhinolaryngology Vol 1, p.335
5. Immunotherapy as a Steroid-Sparing Strategy
In AFRS, allergen immunotherapy (subcutaneous) has Level C evidence (two case-control studies + three prospective case series) showing:
- Reduced reliance on post-operative steroids
- Reduced post-operative exacerbations
- Lower revision surgery rates (11.1% with IT vs. 33% without IT, Bassichis et al.)
Immunotherapy does not appear to cause unusual side effects or immune complex formation in AFRS patients. It is especially useful for reducing long-term steroid burden. - Scott-Brown's Otorhinolaryngology Vol 1, p.262
Key Takeaways
- AFRS = steroids are central: oral perioperatively + post-op taper, then maintain on topical steroids. The disease is essentially driven by eosinophilic hypersensitivity, not infection, so immune suppression is appropriate.
- Fungal ball = no steroids needed after surgical clearance.
- Invasive FRS = steroids are contraindicated - they worsen immunosuppression and promote uncontrolled fungal invasion.
- Steroid side effects and recurrence after cessation are ongoing concerns in AFRS; immunotherapy and antifungals serve as steroid-sparing adjuncts.
- The 2025 systematic review by Shafik et al. (PMID 40270102) on post-operative oral corticosteroids after sinus surgery for CRS provides the most recent high-level evidence on this topic, though it covers CRS broadly rather than AFRS specifically.
This is a shared conversation. Sign in to Orris to start your own chat.